Search Login Register

irinotecan (Camptosar) Summary

Description: RN given for mono-HCL(S)-isomer; NK012 is a polymeric micellar preparation of SN-38; structure given in first source, 7-ethyl-10-hydroxycamptothecin is active metabolite

Also Known As: Camptosar; CPT 11; SN 38; 7-ethyl-10-hydroxycamptothecin; ALIRI cpd; CPT-11; Irrinotecan; KN012 compound; NK012 compound; Pfizer brand of irinotecan hydrochloride; SN 38 11; SN-38; SN-38-11; camptothecin-11; irinotecan hydrochloride

Networked: 5122 relevant articles (891 outcomes, 1881 trials/studies) for this Drug

Key Diseases for which irinotecan is Relevant

  1. Colorectal Neoplasms (Colorectal Cancer) : 347 outcomes 656 studies in 1699 results
  2. Neoplasms (Cancer) : 185 outcomes 379 studies in 1490 results
  3. Neoplasm Metastasis (Metastasis) : 67 outcomes 70 studies in 404 results
  4. Stomach Neoplasms (Stomach Cancer) : 50 outcomes 114 studies in 323 results
  5. Colonic Neoplasms (Colon Cancer) : 40 outcomes 59 studies in 326 results
Show All >>

Drugs Related to irinotecan

  1. Fluorouracil (Carac)
  2. oxaliplatin (Eloxatin)
  3. Leucovorin (Folinic Acid)
  4. bevacizumab
  5. irinotecan (Camptosar)
  6. Cisplatin (Platino)
  7. capecitabine (Xeloda)
  8. cetuximab (Erbitux)
  9. gemcitabine
  10. Paclitaxel (Taxol)
Show All >>

Therapies Related to irinotecan

  1. Drug Therapy (Chemotherapy)
  2. Combination Drug Therapy (Combination Chemotherapy)
  3. Heterologous Transplantation (Xenotransplantation)
  4. Radiotherapy
  5. Microspheres (Microsphere)
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.